Leurosine

CAS : 23360-92-1

Ref. 3D-YAA36092

Informations sur le produit

• Nom: Leurosine
• Synonymes: (2alpha,2'beta,3alpha,3'beta,4alpha,5beta,19beta)-O~3~',3'-cyclovincaleukoblastine, (3′α,4′α)-4′-Deoxy-3′,4′-epoxyvincaleukoblastine, 1H-Indolizino[8,1-cd]carbazole, vincaleukoblastine deriv., 2H-3,13-Methanooxireno[9,10]azacycloundecino[5,4-b]indole, vincaleukoblastine deriv., Amotin, Amotin [Russian], Brn 0079636, Hsdb 3506, NSC 528004, Vincaleukoblastine, 4'-deoxy-3',4'-epoxy-, (3'alpha,4'alpha)-, Vincaleukoblastine, 4′-deoxy-3′,4′-epoxy-, (3′α,4′α)-, Vinleurosina, Vinleurosina [INN-Spanish], Vinleurosinum, Vinleurosinum [INN-Latin], 4-27-00-09622 (Beilstein Handbook Reference)

Description

Leurosine is an analog of a natural product found in Chinese herbs that has shown potent anticancer activity. It induces apoptosis in cancer cells by inhibiting kinases such as cyclin-dependent protein kinase, which are involved in cell cycle regulation. Leurosine has been found to be effective against a range of human tumor cell lines and may have potential for the treatment of various types of cancer. It also shows promise as an inhibitor of other protein kinases involved in cancer development and progression. The compound is excreted in urine, indicating that it may be suitable for use as a therapeutic agent for cancer patients.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 809 g/mol
• Formule: C₄₆H₅₆N₄O₉
• Degré de pureté: Min. 95%